Viscosupplementation

What is Viscosupplementation?

Viscosupplementation is a medical treatment primarily used for osteoarthritis (OA), especially in the knee involving injecting hyaluronic acid (HA) into the affected joint to restore the synovial fluid’s viscoelastic properties, potentially reducing pain and improving function.

Here's a more detailed explanation:

What it is?

Viscosupplementation involves injecting a gel-like fluid containing hyaluronic acid (HA) into the joint space.

What is HA?

Hyaluronic acid (HA) is a naturally occurring substance in the body, particularly in the synovial fluid that lubricates joints. In osteoarthritis, the quality and quantity of this fluid deteriorate, reducing its ability to cushion and protect the joint.

Why it's used:

In OA, the cartilage in joints breaks down, leading to reduced lubrication and pain. Viscosupplementation aims to restore this lubrication and shock absorption by replacing the HA.

How it works:

The injected HA is thought to restore the rheological properties of the synovial fluid, which can help with pain relief, improved joint function, and potentially even chondroprotection (protection of the cartilage).

Conditions it's used for:

Viscosupplementation is primarily used for moderate to severe knee OA, but it can also be used in other joints.

Types of HA preparations:

Viscosupplementation involves the injection of exogenous hyaluronic acid, often formulated as sodium hyaluronate. There are different types of HA preparations, including low-molecular-weight, high-molecular-weight, and cross-linked HA.

Benefits of Viscosupplementation

Pain relief: Helps reduce joint pain, especially in mild-to-moderate OA.
Improved mobility: Can restore or improve joint function and flexibility.
Delays surgery: May help delay the need for total knee replacement in some patients.
Low risk of side effects: Generally well-tolerated with minor local reactions (pain, swelling or discomfort at the injection site).
Alternative to NSAIDs: Provides pain relief without the systemic side effects of long-term non-steroidal anti-inflammatory drug use.

Limitations

Best suited for early to moderate OA.
May not be effective in severe OA or when joint damage is extensive.
Requires repeat injections, often every 6–12 months.
Results may vary—some patients experience significant relief, others do not.

Alternatives

Other treatments for OA include physical therapy, medication, and in some cases, surgery.

Prevalence Worldwide

In the United States, viscosupplementation has been widely used since FDA approval in the late 1990s. It is estimated that millions of injections are given annually, though use has declined slightly in recent years due to mixed clinical guidelines.

Europe and Japan have also adopted viscosupplementation broadly, with some countries using it earlier and more aggressively than the U.S.

Globally, its adoption is more common in developed countries with established orthopedic and pain management practices.

Prevalence in India

In India, viscosupplementation is increasingly popular, especially in urban areas with access to advanced orthopedic care.

It’s more commonly used among the middle and upper economic classes, given the cost of treatment (which can range from ₹10,000 to ₹30,000 or more per injection, depending on the product).

Indian orthopedic societies have acknowledged its role in OA management, though it’s not as routine as in the West.

Limited public sector use due to cost constraints, but private hospitals and clinics frequently offer it as part of non-surgical OA management.

This is for informational purposes only. For medical advice or diagnosis, consult a professional.

Shopping cart